Table 1 Demographic and clinical characteristics of the studied cohort
Characteristics | Total cases n = 332 (100%) | SPB n = 117 (35.2%) | Non-SPB n = 215 (64.8%) | P value |
|---|---|---|---|---|
Age | Â | Â | Â | 0.069 |
 Mean ± SD (years) | 61.2 ± 11.3 | 59.7 ± 10.8 | 62 ± 11.5 |  |
 Median (range-years) | 62 (19–90) | 62 (19–90) | 63 (25–80) |  |
Gender | Â | Â | Â | 0.221 |
 Male | 223 (67.2%) | 84 (71.8%) | 139 (64.7%) |  |
 Female | 109 (32.8%) | 33 (28.2%) | 76 (35.3%) |  |
Presentation | ||||
 Fever | 47 (14.2%) | 25 (21.4%) | 22 (10.2%) | 0.008 |
 Abdominal pain | 65 (19.6%) | 40 (34.2%) | 25 (11.6%) | < 0.001 |
 Jaundice | 167 (72%) | 68 (58.1%) | 99 (46%) | 0.039 |
 Hepatic encephalopathy | 239 (21.4%) | 87 (74.4%) | 152 (70.7%) | 0.524 |
 UGIB | 128 (38.6%) | 46 (39.3%) | 82 (38.1%) | 0.906 |
 HCC | 94 (28.3%) | 31 (26.5%) | 63 (29.3%) | 0.341 |
Serology | ||||
 HCV | 258 (77.7%) | 93 (79.5%) | 165 (76.7%) | 0.533 |
 HBV | 18 (5.4%) | 4 (3.4%) | 14 (6.5%) |  |
 HBV+HCV | 9 (2.7%) | 2 (1.7%) | 7 (3.3%) |  |
 Negative | 47 (14.2%) | 18 (15.4%) | 29 (13.5%) |  |
Child class | ||||
 B | 88 (26.5%) | 24 (20.5%) | 64 (29.8%) | 0.07 |
 C | 244 (73.5%) | 93 (79.5%) | 151 (70.2%) |  |
Child score | 10.9 ± 2.1 | 11 ± 2 | 11.2 ± 1.9 | 0.132 |
MELD score | 19.1 ± 7.8 | 19.7 ± 7.5 | 20.6 ± 7.6 | 0.111 |